Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
First Trust Canada Launches New Enhanced Income ETF on Cboe Canada
-
Best’s Special Report: Smaller Companies Face Cash Flow Crunch from Uptick in U.S. Life/Annuity Surrenders
-
Cantargia Presents Promising Preclinical Results on Nadunolimab With Antibody-Drug Conjugates at Major Immuno-Oncology Conference
-
American Resources Corporation’s ReElement Technologies Updates Progress On Marion Super Site For United States’ Largest Combined Rare Earth and Lithium Refining Facility
-
Healthcare Integrated Technologies, Inc. Appoints Caleb Dixon as Chief Customer Officer
-
TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition
-
Nisun International Expands Fully into the Rubber Supply Chain Industry by Signing Supply Chain Contracts with an Initial Order of Approximately $13.5 Million
-
Genentech to Present New and Encouraging Long-term Follow-up Data Across Broad Hematology Portfolio at ASH 2024
-
Kite to Highlight Industry-Leading CAR T-Cell Therapy Portfolio at ASH 2024, Including Positive Survival Outcomes in Both Clinical Trials and the Real-World
-
Discover Fatboy’s Ultimate Holiday Gift Guide: Unique & Playful Gifts for Every Home in Canada
-
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024
-
Celebrity Dog “Swaggy Wolfdog” Refuses Candidate Endorsement, Launches Petition to End Pet Fees for Renters
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
Integrated Water Services, Inc. Strengthens Turnkey Solutions with Acquisition of Hi-Line Industries
-
Allogene Therapeutics to Present New Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Adult Patients with CD70 Positive Advanced Renal Cell Carcinoma (RCC) at the International Kidne
-
CobbleStone Software Recognized in Multiple G2 Fall 2024 Reports For Its CLM Software Offering
-
Anaergia to Strengthen Its Market Position With New Office in Japan
-
Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
-
Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting
-
AQUALAB Launches SKALA Dry
-
ORGANO® Receives Awards for Quality Coffee at The Global Beauty and Wellness Awards 2024
-
PizzaForno Inks 40-Unit Development Deal in Michigan
-
HighByte Announces Changes to Board of Directors
-
Cenntro’s Avantier Motors Corporation Expands European Offerings with Launch of Avantier Ex and Avantier Commuter Electric Vehicles
-
Satisfaction With Provider Services Edges Up, as Companies Seek More Innovation, ISG Study Shows
-
Walker & Dunlop Sources $110 Million for Refinance of NYC Multifamily Portfolio
-
OMNIVISION Announces Patent Litigation Victory Against VisionX Technologies, LLC
-
Boomer Benefits Unveils Insightful Article on Medicare Part D Payment Plan for 2025
-
METAGENOMI (NASDAQ: MGX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
-
Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition
-
Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
-
Umoja Biopharma Announces Oral and Poster Presentations at the 66th American Society of Hematology Annual Meeting
-
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
-
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and E
-
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
-
Alchemi's ShieldCRS Insider Threat Protection Platform Honored with Industry Accolades for Startup Achievement
-
Be Biopharma Announces Upcoming Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
-
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
-
MedAllies Earns 2024 Great Place To Work Certification™
-
Envisio Names Craig Ross as CEO
-
Carahsoft to Host Webinar on Ensuring ICAM Survivability for Access in Disconnected, Degraded, Intermittent, and Low-Bandwidth (DDIL) Environments
-
Vheda Health Awarded Centene's Partnership Purpose Award
-
Announcing the Launch of Hypesquad.ai: AI-Powered Engagement, Comment Management, and Monetisation Tools
-
AMC Health Receives Expanded FDA Clearance for Advanced Virtual Care and Risk Prediction Technology
-
Could use a vacation right now: Elsa Pataky and Chris Hemsworth Partner with Experience Abu Dhabi
-
Mitchell and Protech Join Forces to Streamline Calibration Detection
-
Pompeian Sustainably Grown Certified Olive Oil
-
CXApp Inc. (Nasdaq: CXAI) Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
-
Great Atlantic to Attend Newfoundland and Labrador Mineral Resources Review 2024 Conference
